NL-OMON31557撤回不适用
A double blind placebo-controlled crossover study to determine the effects of atomoxetine on event-related potentials in response to auditory oddball stimuli during an on-the-road driving test in adult patients with attention-deficit hyperactivity disorder - Effects of atomoxetine on attention and driving in adult ADHD
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •-Adult men and women diagnosed with ADHD
- •-Written informed consent
- •-Possession of a valid driver's license for at least 3 years
- •-For women of childbearing potential, a negative urine beta-HCG pregnancy test result at test days
- •-Normal static binocular acuity, corrected or uncorrected
- •-Normal hearing
- •-Be considered as reliable and mentally capable of adhering to the protocol
排除标准
- •-Depression or anxiety disorder, unless controlled and stable with medication
- •-Current drug use (positive urine drug screen on the presence of amphetamines, barbiturates, benzodiazepines, cocaine, and opiates at test days)
- •-Use of psychoactive medication
- •-Positive alcohol breath test
- •-Prior enrolment in the same study
- •-Participation in another clinical trial
研究者
相似试验
进行中（未招募）
不适用
A double blind placebo controlled crossover study to determine the effects of atomoxetine on event-related potentials in response to auditory oddball stimuli during an on-the-road driving test in adult patients with attention deficit hyperactivity disorder - Effects of atomoxetine on attention and driving in adult ADHDThe effects of atomoxetine on driving performance, attention and response inbihition are studied in adult patients with attention-deficit hyperactivity disorderEUCTR2007-001855-20-NLFaculty of Social Sciences, Utrecht University30
已完成
2 期
The use of APL510 to improve the length of day time sleep in subjects working permanent night-shiftsMental and Behavioural DisordersNonorganic sleep disordersInsomniaISRCTN15733268Alliance Pharmaceuticals Ltd (UK)44
已完成
2 期
1.5 versus 3.0 mg APL510 to normalise sleep patterns in elderly subjects with insomniaMental and Behavioural DisordersNonorganic sleep disordersInsomniaISRCTN82088636Alliance Pharmaceuticals Ltd (UK)80
进行中（未招募）
1 期
A double-blind placebo-controlled cross-over study to determine if melatonin can improve the length of day time sleep in subjects with transient misalignment of the sleep-wake cycle as a result of working permanent night shifts.Transient misalignment of the sleep-wake cycle as a result of working night shifts (insomnia in night shift workers)EUCTR2005-000120-17-GBAlliance Pharmaceuticals Ltd60
进行中（未招募）
1 期
A double-blind placebo controlled cross-over study to determine if 1.5 and 3mg of APL510 can normalise sleep patterns in elderly subjects with difficulty in maintenance of sleep and/or initiating sleep onset. - N/AEUCTR2004-003939-32-GBAlliance Pharmaceuticals Ltd80